このアイテムのアクセス数: 64
このアイテムのファイル:
| ファイル | 記述 | サイズ | フォーマット | |
|---|---|---|---|---|
| s12886-022-02514-8.pdf | 1.22 MB | Adobe PDF | 見る/開く |
| タイトル: | Punctate inner choroidopathy immediately after COVID-19 infection: a case report |
| 著者: | Miyata, Manabu    https://orcid.org/0000-0002-7574-1749 (unconfirmed)Ooto, Sotaro Muraoka, Yuki |
| 著者名の別形: | 宮田, 学 大音, 壮太郎 村岡, 勇貴 |
| キーワード: | COVID-19 Oral prednisolone Punctate inner choroidopathy |
| 発行日: | 7-Jul-2022 |
| 出版者: | Springer Nature BMC |
| 誌名: | BMC Ophthalmology |
| 巻: | 22 |
| 論文番号: | 297 |
| 抄録: | BACKGROUND: Punctate inner choroidopathy (PIC) is a rare idiopathic inflammatory multifocal chorioretinopathy. Although the etiology of PIC is unknown, it is proposed to be an autoimmune disease that arises in the context of polygenic susceptibility triggered by an environmental stimulus, such as infection. We reported a case of PIC immediately after COVID-19 infection. CASE PRESENTATION: A 25-year-old woman complained of blurred vision in the right eye six days after the symptoms of COVID-19 infection first appeared. The patient visited our hospital and underwent comprehensive ophthalmological examination 18 days after the initial COVID-19 symptoms. Based on the characteristic fundus features observed with multimodal imaging, retinal specialists made a diagnosis of PIC. The patient was affected with high myopia. As her general COVID-19 symptoms disappeared, the patient was prescribed oral prednisolone 30 mg/day for 14 days to treat PIC. Fundus abnormality decreased and her ocular symptoms improved. No side effects were observed, including the recurrence of general COVID-19 symptoms. CONCLUSION: We experienced an extremely rare case of PIC immediately after COVID-19 infection and showed the potential safety and effectiveness of oral prednisolone in treating PIC in the active phase after the disappearance of the general COVID-19 infection symptoms. |
| 著作権等: | © The Author(s) 2022. This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. |
| URI: | http://hdl.handle.net/2433/283377 |
| DOI(出版社版): | 10.1186/s12886-022-02514-8 |
| PubMed ID: | 35799141 |
| 出現コレクション: | 学術雑誌掲載論文等 |
このアイテムは次のライセンスが設定されています: クリエイティブ・コモンズ・ライセンス
